Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of IGFBP3 binding to TMEM219 for treatment of intestinal diseases

Inhibitors of IGFBP3 binding to TMEM219 for treatment of intestinal diseases

US Patent 10682391 · Granted Jun 16, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies and uses thereof2025
Antibodies and uses thereof2025
TMEM219 antibodies and therapeutic uses thereof2025
TMEM219 antibodies and therapeutic uses thereof2025
Prevention and treatment of diabetic nephropathy2024
Treatment of type 1 diabetes and autoimmune diseases or disorders2024
PD-L1 expressing hematopoietic stem cells and uses2023
Method of preventing and treating type 1 diabetes, allograft rejection and lung 2022
Prevention and treatment of diabetic nephropathy2022
Inhibitor of IGFBP3/TMEM219 axis and diabetes2021
Inhibitor of IGFBP3/TMEM219 axis and diabetes2021
PD-L1 expressing hematopoietic stem cells and uses2020